Follow us on
Standard of care

Treatment that is accepted by medical experts as a proper treatment for a certain type of disease and that is widely used by healthcare professionals. Also called best practice, standard medical care, and standard therapy.
Select RSS URL
Data Addressing Patient And Physician Barriers To Clinical Trials To Be Presented By Experts
Source:  Clinical Trials/Drug Trials News from Medical News Today
Researchers from University Hospitals Case Medical Center's (UHCMC) Seidman Cancer Center in Cleveland, OH, will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials...
Combination Drug Therapy May Be Best Treatment For Osteoporosis
Source:  Clinical Trials/Drug Trials News from Medical News Today
The combination of two different drugs for osteoporosis was found to increase bone mineral density (BMD) more than treatment with either drug alone, according to the results of a small clinical trial published in The Lancet...
New Mathematical Modeling Approach To Analyzing Colorectal Cancer Clinical Trial Data
Source:  Clinical Trials/Drug Trials News from Medical News Today
Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab...
Analysis Shows Cancer Biorepository Speeds Clinical Trials, Drug Development
Source:  Clinical Trials/Drug Trials News from Medical News Today
Researchers at Moffitt Cancer Center say identifying and selecting participants for phase II cancer clinical trials from a centralized warehouse of patient-donated biological data expedites participant accrual, reduces trial size, saves money, and may speed test drugs through the drug development pipeline...
Lantheus Medical Imaging To Proceed With Flurpiridaz F 18 Phase 3 Clinical Program Based On Interim Analysis Of Data From First Phase 3 Study
Source:  Clinical Trials/Drug Trials News from Medical News Today
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced an important milestone for its Phase 3 flurpiridaz F 18 clinical program. An interim analysis of the first of two Phase 3 studies has met the criteria for completion...
Merck And Pfizer Collaborate To Develop New Diabetes Drug
Source:  Clinical Trials/Drug Trials News from Medical News Today
Two pharmaceutical companies - Merck & Co Inc. and Pfizer Inc. - have just announced that they have partnered up for the development of the type 2 diabetes drug ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor...
Sofosbuvir Offers High Cure Rate For Two Hepatitis C Subtypes
Source:  Clinical Trials/Drug Trials News from Medical News Today
Sofosbuvir, a new drug, is offering impressive cure rates for Hepatitis C patients with two subtypes of the disease - genotypes 2 and 3, according to researchers led by Weill Cornell Medical College. Approximately 1 in every 4 hepatitis C patients in the USA has one of these two subtypes...
Patient Asks Why Drug Companies Are "Trying To Prevent Disclosure Of Trial Data"
Source:  Clinical Trials/Drug Trials News from Medical News Today
A personal view from a patient with a potentially life-limiting illness published this week on bmj.com asks why pharmaceutical giants are trying to prevent the disclosure of trial data...
Recruitment And Prescreening For Clinical Pain Trials Enhanced By Web-Based Tools
Source:  Clinical Trials/Drug Trials News from Medical News Today
Researchers are suggesting new ways to use existing Internet tools to recruit more study participants for clinical pain trials and to increase the likelihood they will remain throughout the study period...
New Protocol Design Approaches Will Improve Clinical Trial Performance And Efficiency, According To Tufts Center For The Study Of Drug Development
Source:  Clinical Trials/Drug Trials News from Medical News Today
Growing protocol complexity-responsible for longer clinical study times, greater difficulty in recruiting volunteers, and rising drug development costs-is spurring new approaches to optimizing protocol design, according to leaders from the research-based drug industry recently convened by the Tufts Center for the Study of Drug Development...